A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma

Lung squamous cell cancer (SCC) and accounts for approximately 20%–30% of all lung cancers. Surgery, chemotherapy and radiotherapy are the main treatments for lung SCC patients. A case with lung SCC patient who was treated using iodine 125 seeds (I-125) because the location of the tumor was adjacent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Qingtao, Pan, Chi, Guo, Qing, Wang, Peng, Yang, Yan, Zhang, Wei, Dai, Shengbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Clinical Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125098/
https://www.ncbi.nlm.nih.gov/pubmed/35615569
http://dx.doi.org/10.1177/15593258221103373
Descripción
Sumario:Lung squamous cell cancer (SCC) and accounts for approximately 20%–30% of all lung cancers. Surgery, chemotherapy and radiotherapy are the main treatments for lung SCC patients. A case with lung SCC patient who was treated using iodine 125 seeds (I-125) because the location of the tumor was adjacent to the great vessels. I-125 is an ideal brachytherapy for lung SCC patients with large masses who lost the chance of operation. I-125 is an adjuvant therapy, combined with chemotherapy and molecular targeting therapy might serve to improve the prognosis of lung SCC patients.

Ejemplares similares